Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

NASDAQ:RGC

Overview | Financials
Company Name Regencell Bioscience Holdings Limited
Symbol RGC
Currency USD
Price 4.77
Market Cap 62,071,533
Dividend Yield 0%
52-week-range 3.03 - 32.44
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Yat-Gai Au
Website https://www.regencellbioscience.com

An error occurred while fetching data.

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway

Related Stocks

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

62.82 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

76.79 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

2.24 USD

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

14.25 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

9.25 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

7.14 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

1.42 USD

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

3.19 USD

Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

MNMD

7.08 USD

Financials

Numbers are in millions USD

Numbers are in millions USD